Article
<p class="MsoNormal" style="margin-bottom: 12.0pt; text-align: left; mso-line-height-alt: 14.0pt; layout-grid-mode: char; mso-layout-grid-align: none;" align="left"><sup>161</sup>Tb-BPAMD as a High-Affinity Agent for Skeletal Targeting: Radiochemical and Biodistribution Insights
2026-01-12
Abstract excerpt
<h4>Background: </h4> Bone-seeking radiopharmaceuticals based on bisphosphonates enable targeted therapy of skeletal metastases. They are ideal carriers for therapeutic radionuclides such as Terbium-161 (161Tb), a β-emitter that additionally releases short-range conversion and Auger electrons, which may enhance radiation dose delivery to small lesions. This study aimed to investigate the potential of the specific...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 8fdc0849-4c09-5efc-a1f4-efb567466d88
- DOI
- 10.20944/preprints202601.0694.v1
